Dialog Semiconductor Plc (XTRA:DLG) currently has a current ratio of 2.77. The current ratio, which is also known as the working capital ratio, is a liquidity ratio that displays the proportion of current assets of a business relative to the current liabilities. The ratio is simply calculated by dividing current liabilities by current assets. The ratio may be used to provide an idea of the ability of a certain company to pay back its liabilities with assets. Typically, the higher the current ratio the better, as the company may be more capable of paying back its obligations and in turn a more healthy balance sheet.

Figuring out when to sell a stock can be just as important as deciding what stocks to buy at the outset. Some investors may refuse to sell based on various factors. Investors may have become stubborn, too emotionally attached, or set too high of an expectation for a stock. Holding on to a stock for way too long in order to squeeze every last drop of profit out of a price move may leave the investor desperately searching for answers in the future. Investors may have different checklists for when it is time to sell a stock. Of course this depends largely on the individual and how much is at risk. Often times, investors will make a move to sell when the fundamentals drastically change, the dividend is cut, or a previous set target price has been hit. Getting out of a position at the right time is obviously not easy, but it may become a bit easier with time and research.

**Yield**

The Q.i. Value of Dialog Semiconductor Plc (XTRA:DLG) is 21.00000. The Q.i. Value is a helpful tool in determining if a company is undervalued or not. The Q.i. Value is calculated using the following ratios: EBITDA Yield, Earnings Yield, FCF Yield, and Liquidity. The lower the Q.i. value, the more undervalued the company is thought to be. The Value Composite One (VC1) is a method that investors use to determine a company’s value. The VC1 of Dialog Semiconductor Plc (XTRA:DLG) is 37. A company with a value of 0 is thought to be an undervalued company, while a company with a value of 100 is considered an overvalued company. The VC1 is calculated using the price to book value, price to sales, EBITDA to EV, price to cash flow, and price to earnings. Similarly, the Value Composite Two (VC2) is calculated with the same ratios, but adds the Shareholder Yield. The Value Composite Two of Dialog Semiconductor Plc (XTRA:DLG) is 45.

**
**

Volatility & Price

Stock volatility is a percentage that indicates whether a stock is a desirable purchase. Investors look at the Volatility 12m to determine if a company has a low volatility percentage or not over the course of a year. The Volatility 12m of Dialog Semiconductor Plc (XTRA:DLG) is 46.071700. This is calculated by taking weekly log normal returns and standard deviation of the share price over one year annualized. The lower the number, a company is thought to have low volatility. The Volatility 3m is a similar percentage determined by the daily log normal returns and standard deviation of the share price over 3 months. The Volatility 3m of Dialog Semiconductor Plc (XTRA:DLG) is 40.018600. The Volatility 6m is the same, except measured over the course of six months. The Volatility 6m is 34.818300.

We can now take a quick look at some historical stock price index data. Dialog Semiconductor Plc (XTRA:DLG) presently has a 10 month price index of 1.91492. The price index is calculated by dividing the current share price by the share price ten months ago. A ratio over one indicates an increase in share price over the period. A ratio lower than one shows that the price has decreased over that time period. Looking at some alternate time periods, the 12 month price index is 2.52259, the 24 month is 0.92785, and the 36 month is 1.30969. Narrowing in a bit closer, the 5 month price index is 1.37706, the 3 month is 1.13417, and the 1 month is currently 1.13992.

**Key Metrics**

The Piotroski F-Score is a scoring system between 1-9 that determines a firm’s financial strength. The score helps determine if a company’s stock is valuable or not. The Piotroski F-Score of Dialog Semiconductor Plc (XTRA:DLG) is 4. A score of nine indicates a high value stock, while a score of one indicates a low value stock. The score is calculated by the return on assets (ROA), Cash flow return on assets (CFROA), change in return of assets, and quality of earnings. It is also calculated by a change in gearing or leverage, liquidity, and change in shares in issue. The score is also determined by change in gross margin and change in asset turnover.

The ERP5 Rank is an investment tool that analysts use to discover undervalued companies. The ERP5 looks at the Price to Book ratio, Earnings Yield, ROIC and 5 year average ROIC. The ERP5 of Dialog Semiconductor Plc (XTRA:DLG) is 1870. The lower the ERP5 rank, the more undervalued a company is thought to be. The MF Rank (aka the Magic Formula) is a formula that pinpoints a valuable company trading at a good price. The formula is calculated by looking at companies that have a high earnings yield as well as a high return on invested capital. The MF Rank of Dialog Semiconductor Plc (XTRA:DLG) is 2034. A company with a low rank is considered a good company to invest in. The Magic Formula was introduced in a book written by Joel Greenblatt, entitled, “The Little Book that Beats the Market”.

The Leverage Ratio of Dialog Semiconductor Plc (XTRA:DLG) is 0.036558. Leverage ratio is the total debt of a company divided by total assets of the current and past year divided by two. Companies take on debt to finance their day to day operations. The leverage ratio can measure how much of a company’s capital comes from debt. With this ratio, investors can better estimate how well a company will be able to pay their long and short term financial obligations.

**C-Score**

Dialog Semiconductor Plc (XTRA:DLG) currently has a Montier C-score of 4.00000. This indicator was developed by James Montier in an attempt to identify firms that were cooking the books in order to appear better on paper. The score ranges from zero to six where a 0 would indicate no evidence of book cooking, and a 6 would indicate a high likelihood. A C-score of -1 would indicate that there is not enough information available to calculate the score. Montier used six inputs in the calculation. These inputs included a growing difference between net income and cash flow from operations, increasing receivable days, growing day’s sales of inventory, increasing other current assets, decrease in depreciation relative to gross property plant and equipment, and high total asset growth.

Some investors may succeed spectacularly in the market while others fail. There is an emotional component to trading and investing which can pose a big obstacle to trading success. Investors frequently try to optimize every decision for success, but sometimes things just don’t work out as planned. Consistently beating the market may involve heavy amounts of homework, and a necessary rebalancing of the portfolio. In fast paced markets, indecision can have a drastic impact. Investors may have all the bases covered but fail to make a trade based only on the fear of being wrong. Individual investors may need to conquer self-doubt in order to reach optimal performance when picking stocks. This may not come as easily for some as it does for others. When the market is winning, investors may become too complacent given the ease of gains. Staying on top of the investing scene even when everything is good may help to prepare if conditions change and the climate starts to worsen.

The Current Ratio of Editas Medicine, Inc. (NasdaqGS:EDIT) is 8.46. The Current Ratio is used by investors to determine whether a company can pay short term and long term debts. The current ratio looks at all the liquid and non-liquid assets compared to the company’s total current liabilities. A high current ratio indicates that the company does not have trouble managing their working capital. A low current ratio (when the current liabilities are higher than the current assets) indicates that the company may have trouble paying their short term obligations. It is wise to compare a company’s current ratio to that of other companies in the same industry. It would also be wise to look at the trend of the current ratio for a given company over a given time period.

Figuring out when to exit a certain position can be just as important as deciding which stocks to buy in the first place. Many investors will end up holding onto a loser for far too long. The emotional attachment to a particular stock may keep the investor from making the decision to sell when necessary. On the other side of the coin, investors may hold onto a winner for way too long hoping for further gains. Investors may have to come up with a specific plan for what to do in these situations. Planning ahead may help ease the burden of making the tough portfolio decisions.

**F Score, ERP5 and Magic Formula**

The Piotroski F-Score is a scoring system between 1-9 that determines a firm’s financial strength. The score helps determine if a company’s stock is valuable or not. The Piotroski F-Score of Editas Medicine, Inc. (NasdaqGS:EDIT) is 5. A score of nine indicates a high value stock, while a score of one indicates a low value stock. The score is calculated by the return on assets (ROA), Cash flow return on assets (CFROA), change in return of assets, and quality of earnings. It is also calculated by a change in gearing or leverage, liquidity, and change in shares in issue. The score is also determined by change in gross margin and change in asset turnover.

The ERP5 Rank is an investment tool that analysts use to discover undervalued companies. The ERP5 looks at the Price to Book ratio, Earnings Yield, ROIC and 5 year average ROIC. The ERP5 of Editas Medicine, Inc. (NasdaqGS:EDIT) is 16727. The lower the ERP5 rank, the more undervalued a company is thought to be. The MF Rank (aka the Magic Formula) is a formula that pinpoints a valuable company trading at a good price. The formula is calculated by looking at companies that have a high earnings yield as well as a high return on invested capital. The MF Rank of Editas Medicine, Inc. (NasdaqGS:EDIT) is 16369. A company with a low rank is considered a good company to invest in. The Magic Formula was introduced in a book written by Joel Greenblatt, entitled, “The Little Book that Beats the Market”.

**Shareholder Yield**

The Q.i. Value of Editas Medicine, Inc. (NasdaqGS:EDIT) is 74.00000. The Q.i. Value is a helpful tool in determining if a company is undervalued or not. The Q.i. Value is calculated using the following ratios: EBITDA Yield, Earnings Yield, FCF Yield, and Liquidity. The lower the Q.i. value, the more undervalued the company is thought to be. The Value Composite One (VC1) is a method that investors use to determine a company’s value. The VC1 of Editas Medicine, Inc. (NasdaqGS:EDIT) is 90. A company with a value of 0 is thought to be an undervalued company, while a company with a value of 100 is considered an overvalued company. The VC1 is calculated using the price to book value, price to sales, EBITDA to EV, price to cash flow, and price to earnings. Similarly, the Value Composite Two (VC2) is calculated with the same ratios, but adds the Shareholder Yield. The Value Composite Two of Editas Medicine, Inc. (NasdaqGS:EDIT) is 91.

The **Leverage Ratio** of Editas Medicine, Inc. (NasdaqGS:EDIT) is 0.046949. Leverage ratio is the total debt of a company divided by total assets of the current and past year divided by two. Companies take on debt to finance their day to day operations. The leverage ratio can measure how much of a company’s capital comes from debt. With this ratio, investors can better estimate how well a company will be able to pay their long and short term financial obligations.

**Volatility & Price**

We can now take a quick look at some historical stock price index data. Editas Medicine, Inc. (NasdaqGS:EDIT) presently has a 10 month price index of 0.76270. The price index is calculated by dividing the current share price by the share price ten months ago. A ratio over one indicates an increase in share price over the period. A ratio lower than one shows that the price has decreased over that time period. Looking at some alternate time periods, the 12 month price index is 0.65469, the 24 month is 1.43403, and the 36 month is 0.96646. Narrowing in a bit closer, the 5 month price index is 1.22129, the 3 month is 0.94979, and the 1 month is currently 1.13983.

Stock volatility is a percentage that indicates whether a stock is a desirable purchase. Investors look at the Volatility 12m to determine if a company has a low volatility percentage or not over the course of a year. The Volatility 12m of Editas Medicine, Inc. (NasdaqGS:EDIT) is 71.901200. This is calculated by taking weekly log normal returns and standard deviation of the share price over one year annualized. The lower the number, a company is thought to have low volatility. The Volatility 3m is a similar percentage determined by the daily log normal returns and standard deviation of the share price over 3 months. The Volatility 3m of Editas Medicine, Inc. (NasdaqGS:EDIT) is 55.267100. The Volatility 6m is the same, except measured over the course of six months. The Volatility 6m is 64.069300.

**C-Score**

Editas Medicine, Inc. (NasdaqGS:EDIT) currently has a Montier C-score of 0.00000. This indicator was developed by James Montier in an attempt to identify firms that were cooking the books in order to appear better on paper. The score ranges from zero to six where a 0 would indicate no evidence of book cooking, and a 6 would indicate a high likelihood. A C-score of -1 would indicate that there is not enough information available to calculate the score. Montier used six inputs in the calculation. These inputs included a growing difference between net income and cash flow from operations, increasing receivable days, growing day’s sales of inventory, increasing other current assets, decrease in depreciation relative to gross property plant and equipment, and high total asset growth.

Market slides can be troublesome for investors. When markets are moving lower, investors may become extra nervous about certain holdings. With the stock market reaching heightened levels, investors may not be putting too much though into the specific portfolio holdings. This can all change if there is a sudden downturn. Investors who have spent the hours researching their stock picks may be more confident when the tides inevitably turn. Putting in the time to regularly review stock holdings may assist the investor when certain adjustments need to be made. Focusing on developing and maintaining a solid plan may end up being a useful tool when obstacles eventually pop up down the line.

**Receive News & Ratings Via Email** – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with MarketBeat.com’s FREE daily email newsletter.